Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 5
2005 4
2006 2
2007 7
2008 4
2009 9
2010 6
2011 9
2012 5
2013 6
2014 11
2015 8
2016 12
2017 4
2018 6
2019 14
2020 12
2021 15
2022 9
2023 4
2024 6
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML.
Hassan N, Yi H, Malik B, Gaspard-Boulinc L, Samaraweera SE, Casolari DA, Seneviratne J, Balachandran A, Chew T, Duly A, Carter DR, Cheung BB, Norris M, Haber M, Kavallaris M, Marshall GM, Zhang XD, Liu T, Wang J, Liebermann DA, D'Andrea RJ, Wang JY. Hassan N, et al. Among authors: norris m. Blood. 2024 Jul 4;144(1):84-98. doi: 10.1182/blood.2024024072. Blood. 2024. PMID: 38579286 Free PMC article.
Polyamine depletion limits progression of acute leukaemia.
Gao W, Karsa M, Xiao L, Spurling D, Karsa A, Ronca E, Bongers A, Guo X, Mayoh C, Azfar M, Verhelst SHL, Tanaka K, Cheung LC, Kotecha RS, Lock RB, Burns MR, Vangheluwe P, Norris MD, Haber M, Somers K. Gao W, et al. Among authors: norris md. Int J Cancer. 2025 Jun 15;156(12):2360-2376. doi: 10.1002/ijc.35362. Epub 2025 Feb 22. Int J Cancer. 2025. PMID: 39985426
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.
Pandher R, Xue C, Gamble LD, Milazzo G, Di Giacomo S, Murray J, Cheung L, Ferrucci F, Palombo M, Purgato S, Burkhart CA, Fedtsova N, Gleiberman AS, Purmal AA, Korotchkina L, Nikiforov MA, Makarov SS, Telfer TJ, Codd R, Marshall GM, Scott DA, Osterman AL, Gudkov AV, Perini G, Haber M, Norris MD. Pandher R, et al. Among authors: norris md. Proc Natl Acad Sci U S A. 2025 Jun 10;122(23):e2420011122. doi: 10.1073/pnas.2420011122. Epub 2025 Jun 2. Proc Natl Acad Sci U S A. 2025. PMID: 40455982 Free PMC article.
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
Murray JE, Valli E, Milazzo G, Mayoh C, Gifford AJ, Fletcher JI, Xue C, Jayatilleke N, Salehzadeh F, Gamble LD, Rouaen JRC, Carter DR, Forgham H, Sekyere EO, Keating J, Eden G, Allan S, Alfred S, Kusuma FK, Clark A, Webber H, Russell AJ, de Weck A, Kile BT, Santulli M, De Rosa P, Fleuren EDG, Gao W, Wilkinson-White L, Low JKK, Mackay JP, Marshall GM, Hilton DJ, Giorgi FM, Koster J, Perini G, Haber M, Norris MD. Murray JE, et al. Among authors: norris md. Nat Commun. 2024 Jul 11;15(1):5585. doi: 10.1038/s41467-024-49871-0. Nat Commun. 2024. PMID: 38992040 Free PMC article.
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Hogarty MD, Ziegler DS, Franson A, Chi YY, Tsao-Wei D, Liu K, Vemu R, Gerner EW, Bruckheimer E, Shamirian A, Hasenauer B, Balis FM, Groshen S, Norris MD, Haber M, Park JR, Matthay KK, Marachelian A. Hogarty MD, et al. Among authors: norris md. Br J Cancer. 2024 Mar;130(5):788-797. doi: 10.1038/s41416-023-02525-2. Epub 2024 Jan 10. Br J Cancer. 2024. PMID: 38200233 Free PMC article. Clinical Trial.
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.
Azfar M, Gao W, Van den Haute C, Xiao L, Karsa M, Pandher R, Karsa A, Spurling D, Ronca E, Bongers A, Guo X, Mayoh C, Fayt Y, Schoofs A, Burns MR, Verhelst SHL, Norris MD, Haber M, Vangheluwe P, Somers K. Azfar M, et al. Among authors: norris md. Mol Oncol. 2025 Mar;19(3):913-936. doi: 10.1002/1878-0261.13789. Epub 2025 Feb 21. Mol Oncol. 2025. PMID: 39981745 Free PMC article.
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.
Han JZR, Phimmachanh M, Hastings JF, Leong KH, Ng BH, Ni J, Fontaine-Titley A, Cadell AL, O'Donnell YE, Clearwater M, Kamili A, Haber M, Norris M, Timpson P, Trahair TN, Fletcher JI, Fey D, Kolch W, Latham SL, Croucher DR. Han JZR, et al. Among authors: norris m. Sci Adv. 2025 Nov 28;11(48):eady5599. doi: 10.1126/sciadv.ady5599. Epub 2025 Nov 28. Sci Adv. 2025. PMID: 41313779 Free PMC article.
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.
Hanssen KM, Murray J, Pandher R, Alfred S, Gamble LD, Brand J, Mosmann E, Kusuma FK, Mak C, Kearns A, Kamili A, Atkinson C, Minchaca AZ, Bertoldo J, Ziegler DS, Mussai F, Cheng PNM, Norris MD, Fletcher JI, Haber M. Hanssen KM, et al. Among authors: norris md. J Exp Clin Cancer Res. 2025 Aug 14;44(1):239. doi: 10.1186/s13046-025-03502-8. J Exp Clin Cancer Res. 2025. PMID: 40813699 Free PMC article.
156 results